By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Phoenix RelationsPhoenix RelationsPhoenix Relations
  • Home
  • Categories
    • CrimeUnlimited
    • Economy
    • Education
    • Entertainment
    • HealthHot
    • Exclusives
    • News100+
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • About
  • Privacy Policy
  • Contact Us
Reading: Tremendous Hope As Novel Cystic Fibrosis Treatment Transforming Lives
Share
Sign In
Notification Show More
Font ResizerAa
Phoenix RelationsPhoenix Relations
Font ResizerAa
Search
  • Home
  • About Us
  • Blog
  • Categories
    • Crime
    • Economy
    • Education
    • Entertainment
    • Health
    • Exclusives
    • News
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • Contact
  • Privacy Policy
Have an existing account? Sign In
Follow US
  • Advertise
© 2024 Phoenix Relations. All Rights Reserved.
Health

Tremendous Hope As Novel Cystic Fibrosis Treatment Transforming Lives

Phoenix Relations
Last updated: 27 September 2022 18:32
Phoenix Relations
Share
5 Min Read
SHARE

David Fiant says his cystic fibrosis and the arduous therapy it required was so bad he “could no longer tell if I was living to heal myself or healing myself to live”.

 

 


While waiting for a lung transplant, he was on oxygen therapy and had a six-hour daily care regime, as well as three to four weeks of antibiotic infusions a year.

 

 

Then he became one of the first people in France to take a new triple-drug treatment that has been hailed as a gamechanger for people with the rare life-threatening disorder.

 

 

“I took my first dose of the medicine one morning. By 3pm I was feeling first effects,” he said.

 

 

For the first time in years he was able to shower by himself, climb 15 steps at once and above all “accompany my daughter to buy comic books”, the 40-year-old said.

 

 

When Fiant’s doctor examined him after he started the treatment, he could hear air circulating in his lungs. That had never happened before, he said.

 

 

Fiant’s regime of care has since been drastically cut back — and he has become the president of the French non-profit Vaincre la Mucoviscidose (Defeat Cystic Fibrosis).

 

 

While the treatment’s results were “spectacular”, he emphasised that it was no miracle.

 

 

“There is still no cure for cystic fibrosis,” he stressed.

 

 

– Life expectancy rising –
More than 70,000 people worldwide are estimated to suffer from the inherited disease, in which a defective gene causes sticky mucus to build up in the lungs, digestive tract and other parts of the body.

 

 

It causes difficulty breathing as well as long-term complications such as infection which leads patients to have significantly shortened life expectancies.

 

 

However the triple-pill treatment taken by Fiant, which is sold as Kaftrio in Europe and Trikafta in the United States, has had a major impact since the US first approved it in 2019.

 

 

The life expectancy of people with cystic fibrosis born between 2017 and 2021 in the US is now 53, up from 38 a decade ago, according to US non-profit organisation the Cystic Fibrosis Foundation.

 

 

Kaftrio has been hailed as a breakthrough because it targets the underlying cause of the disease, repairing a mutated defect in the CFTR gene.

 

 

The treatment was approved by the European Union’s medicines agency and by Britain in August 2020.

 

 

However, out of the 7,500 cystic fibrosis patients in France, only 40 percent are able to use the treatment.

 

 

It has not been approved for children under the age of six, and 15 percent of patients have a genetic profile that renders the treatment ineffective.

 

 

Around 900 patients who received transplants of organs such as lungs or livers are also ineligible.

 

– ‘Sword of Damocles’ –
Sabrina Perquis, 41, watched the arrival in France of the new treatment with “great hope”.
But she had had a transplant 15 years ago and found out she was not able to take Kaftrio.

 

 

“It was a tough blow,” she admitted.

“When you have had a transplant you live with a sword of Damocles hanging over your head because rejection is always possible,” she added.

 

 

“We are asking not to be forgotten. Research must continue to find a solution for all patients.”

Several research projects are at varying stages of development, searching for an answer for patients with rare genetic mutations.

 

 

Other questions remain, including whether the treatment completely blocks the disease’s progress or merely slows it down, Vaincre la Mucoviscidose vice-president Pierre Foucaud said.

 

 

The number of cystic fibrosis patients who had an organ transplant fell from 21 to just two per quarter in France from 2019 to 2021, spurred by hopes that Kaftrio would render the operation unnecessary.

 

 

“But will these transplants merely be delayed by 10 to 15 years?” Foucaud asked. “We don’t know.”

Kaftrio has “opened up a tremendous hope for all patients” but more needs to be done, he added.

You Might Also Like

President Macron: Hantavirus Situation in France is Now ‘Under Control’

WHO Confirms Malaria Vaccine Success in Ghana, Kenya, and Malawi

WHO Issues Hantavirus Health Advisory as Death Toll Rises to Three

CNN Founder Ted Turner Dies at 87: Legacy of a Media Icon

Australian State Bans Testing Of Illicit Drugs

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article CBN Increases Interest Rate To 15.5%
Next Article Chimamanda Adiche To Receive The W.E.B. Du Bois Medal From Harvard
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

//

We influence 20 million users and we are the number one  news network on the planet

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow
- Advertisement -
Ad imageAd image

Latest News

Nvidia’s board is reportedly ‘not considering’ hiring Jensen
Default Blog 17 November 2026
EU Sanctions Pro-Russian Hacker Group and Propaganda Firm
Press Releases 17 November 2026
Lawyer on the microchip case passcode
Press Releases 17 November 2026
Power Minister Tegbe Reaffirms Tinubu Administration’s Commitment to Improved Electricity Supply
Press Releases 16 November 2026

Technology

  • Advertise with us
  • Terms & Conditions
  • Privacy Policy

Health

  • Advertise

Entertainment

Sign Up for Our Weeky Newsletter

Subscribe to our weekly newsletter to get our newest article/news/articles instantly!

Phoenix RelationsPhoenix Relations
Follow US
© 2024 Phoenix Relations. | All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?